Table 2 Clinico-pathological characteristics of the assessed breast cancer patients
|  | Frequency (N = 31) | Percent (%) | |
|---|---|---|---|
Age | 48.1 ± 11.4 | ||
47 (22–68) | |||
Grade | 2 | 15 | 48.4 |
3 | 16 | 51.6 | |
Tumor type | IDC | 26 | 83.9 |
ILC | 3 | 9.7 | |
IDC + signet ring | 1 | 3.2 | |
IDC + IBC | 1 | 3.2 | |
LN | Negative | 9 | 29.0 |
Positive | 22 | 71.0 | |
Distant metastasis | Negative | 23 | 74.2 |
Positive | 8 | 25.8 | |
ER | Negative | 17 | 54.8 |
Positive | 14 | 45.2 | |
PR | Negative | 17 | 54.8 |
Positive | 14 | 45.2 | |
Her2 | Negative | 24 | 77.4 |
Positive | 7 | 22.6 | |
DCIS | Negative | 22 | 71.0 |
Positive | 9 | 29.0 | |
Capsular invasion | Negative | 13 | 41.9 |
Positive | 18 | 58.1 | |